| Wednesday's Markets | |
|---|---|
| S&P 500 6,625 (-1.36%) |
|
| Nasdaq 22,152 (-1.46%) |
|
| Dow 46,225 (-1.63%) |
|
| Bitcoin $70,817 (-5.02%) |
|
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
Wake up to the latest market news, company insights, and a bit of Foolish fun -- all wrapped up in one quick, easy-to-read email, called Breakfast News. Delivered at 7:30 a.m. ET every single market day. See an example of our weekday Breakfast News email & sign-up below.
The Dow Jones fell 1.63% yesterday, on course for its worst month since 2022, as Federal Reserve Chair Jerome Powell flagged elevated uncertainty and the potential for higher inflation as part of the latest central bank meeting, as officials voted to hold interest rates steady in an 11-1 split.
Rocket Lab (NASDAQ:RKLB) rose over 2% ahead of the opening bell after news broke of a U.S. Department of War contract win worth $190 million over four years, the largest single launch contract in the company's history.
Accenture, IBM (NYSE: IBM), and Kyndryl (NYSE:KD) are competing businesses that cooperate in certain areas -- a relationship best described as "co-opetition."
If your portfolio comprised just these three companies and you bought each of them at the start of the year with the same amount of money and had to buy more shares in one, completely close your position in another, and hold the final stock, what are you choosing to do and why?
Debate with friends and family, or become a member to hear what your fellow Fools are saying!
